The effects of periodontal treatment on the levels of serum lipids and lipoprotein associated phospholipase A2 in patients with chronic periodontitis and metabolic syndrome
10.3969/j.issn.1001-3733.2014.04.022
- VernacularTitle:牙周基础治疗对慢性牙周炎合并代谢综合征患者血脂及血清脂蛋白相关磷脂酶A2的影响
- Author:
Hui WANG
;
Shuzhen SUN
;
Liyan CHEN
- Publication Type:Journal Article
- Keywords:
Chronic periodontitis;
Metabolic syndrome(MS);
Blood lipid
- From:
Journal of Practical Stomatology
2014;(4):547-550
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the effects of periodontal treatment on the levels of serum lipids and lipoprotein associated phospho-lipase A2(LP-PLA2)in patients with chronic periodontitis(CP)and metabolic syndrome(MS).Methods:52 cases of CP with MS were included,the blood lipid levels,clinical periodontal indexes and white blood cell count(WBC)were detected before and 3 months after treatment.Results:Before and after periodontal therapy the levels of AL(mm)were 5.02 ±0.68 and 3.61 ±0.43(P<0.01),PD(mm)4.07 ±0.46 and 2.52 ±0.39(P<0.01),BOP positive loci(%)92.13 ±6.98 and 37.41 ±8.19(P<0.01), PLI 1.38 ±0.29 and 0.89 ±0.27(P<0.05),TG(mmol/L)1.99 ±0.42 and 1.45 ±0.32(P<0.01)and TC(mmol/L)6.11 ± 0.38 and 5.17 ±0.41(P<0.01),HDL(mmol/L)1.06 ±0.22 and 1.41 ±0.19(P<0.05),respectively.Before and after treat-ment WBCs(×103/L)were 6.03 ±0.42 and 5.52 ±0.37(P<0.01),serum LP-PLA2(mg/L)31.02 ±9.81 and 23.89 ±14.15 (P<0.01),respectively.Conclusion:Periodontal therapy can improve the blood lipid levels in patients with CP and MS.
